**Specific Forms of Cardiomyopathy: Genetics, Clinical Presentation and Treatment**

M. Obadah Al Chekakie

[116] Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac tro‐ ponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med

[117] Wilde A, Bhuiyan Z, Crotti L et al Left cardiac sympathetic denervation for catecho‐ laminergic polymorphic ventricular tachycardia. N Engl J Med. (2008); 358:2024–

[118] Wolpert C, Veltmann C et al. Short QT syndrome. In Baars H, van der Smagt, J, Doe‐

[119] Zhang, J., Kumar, A., Stalker, H et al.Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy.Clin. Genet. 2001; 59:248-256. [120] Zhang J, Kumar A, Kaplan L et al. Genetic linkage of a novel autosomal dominant

vendans P, editors. Clinical Cardiogenetics: Springer 2011; p.189-196.

restrictive cardiomyopathy locus. J Med Genet 2005;42:663-665.

1995;332:1058.

2029.

132 Cardiomyopathies

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/55628
